Acadia Pharmaceuticals (ACAD) Short term Debt (2010 - 2012)

Acadia Pharmaceuticals' Short term Debt history runs 3 years deep, the most recent figure standing at $22000.0 for Q1 2012.

• In Q1 2012, Short term Debt changed N/A year-over-year to $22000.0; the TTM figure through Mar 2012 stood at $22000.0 (changed N/A YoY), while the FY2011 annual figure was $32000.0, down 58.97% from the prior year.
• Short term Debt was $22000.0 for Q1 2012 at Acadia Pharmaceuticals, down from $32000.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $78000.0 in Q4 2010 to a low of $22000.0 in Q1 2012.
• Historically, Short term Debt has averaged $41800.0 across 3 years, with a median of $37000.0 in 2011.
• Biggest YoY gain for Short term Debt was 58.97% in 2011; the steepest drop was 58.97% in 2011.
• A 3-year view of Short term Debt shows it stood at $78000.0 in 2010, then tumbled by 58.97% to $32000.0 in 2011, then sank by 31.25% to $22000.0 in 2012.
• The last three Short term Debt figures came in at $22000.0 (Q1 2012), $32000.0 (Q4 2011), and $37000.0 (Q3 2011), per Business Quant data.